These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10597871)

  • 1. Assessing the cardiac safety of ebastine. Epilogue.
    Roberts DJ
    Drug Saf; 1999; 21 Suppl 1():89-92. PubMed ID: 10597871
    [No Abstract]   [Full Text] [Related]  

  • 2. Of oocytes and runny noses.
    Rosen MR
    Circulation; 1996 Aug; 94(4):607-9. PubMed ID: 8772677
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior.
    Pearlstein R; Vaz R; Rampe D
    J Med Chem; 2003 May; 46(11):2017-22. PubMed ID: 12747773
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etiological mechanism of long QT syndrome and the effects of macrolides].
    Kato T
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():118-22. PubMed ID: 11439888
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the cardiac safety of second-generation antihistamines.
    Taglialatela M; Annunziato L
    Allergy; 2000; 55 Suppl 60():22-30. PubMed ID: 10887972
    [No Abstract]   [Full Text] [Related]  

  • 6. Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems.
    Sugiyama A; Satoh Y; Takahara A; Nakamura Y; Shimizu-Sasamata M; Sato S; Miyata K; Hashimoto K
    Eur J Pharmacol; 2003 Apr; 466(1-2):137-46. PubMed ID: 12679150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the cardiac safety of ebastine. Prologue.
    Roberts DJ
    Drug Saf; 1999; 21 Suppl 1():1-3. PubMed ID: 10597862
    [No Abstract]   [Full Text] [Related]  

  • 8. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole.
    Zhou Z; Vorperian VR; Gong Q; Zhang S; January CT
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):836-43. PubMed ID: 10376921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular profile of loratadine.
    Hey JA; Affrime M; Cobert B; Kreutner W; Cuss FM
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():197-9. PubMed ID: 10444237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
    Leurs R; Church MK; Taglialatela M
    Clin Exp Allergy; 2002 Apr; 32(4):489-98. PubMed ID: 11972592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management.
    Anderson ME; Al-Khatib SM; Roden DM; Califf RM;
    Am Heart J; 2002 Nov; 144(5):769-81. PubMed ID: 12422144
    [No Abstract]   [Full Text] [Related]  

  • 12. The inconstancy of the human heart.
    Miller C
    Nature; 1996 Feb; 379(6568):767-8. PubMed ID: 8587597
    [No Abstract]   [Full Text] [Related]  

  • 13. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S; Lacroix P
    Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
    Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
    Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive mechanism for cation modulation of potassium current.
    Numaguchi H; Johnson JP; Petersen CI; Balser JR
    Nat Neurosci; 2000 May; 3(5):429-30. PubMed ID: 10769379
    [No Abstract]   [Full Text] [Related]  

  • 16. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel.
    Chachin M; Katayama Y; Yamada M; Horio Y; Ohmura T; Kitagawa H; Uchida S; Kurachi Y
    Eur J Pharmacol; 1999 Jun; 374(3):457-60. PubMed ID: 10422790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of HERG and Kv1.5 by ketoconazole.
    Dumaine R; Roy ML; Brown AM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology of EAG K+ channels.
    Bauer CK; Schwarz JR
    J Membr Biol; 2001 Jul; 182(1):1-15. PubMed ID: 11426295
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipsychotics, HERG and sudden death.
    Witchel HJ; Hancox JC; Nutt DJ; Wilson S
    Br J Psychiatry; 2003 Feb; 182():171-2. PubMed ID: 12562748
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug block of I(kr): model systems and relevance to human arrhythmias.
    Yang T; Snyders D; Roden DM
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):737-44. PubMed ID: 11602820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.